Could Smart Watches And Phone Apps Detect Alzheimer’s Years Before Symptoms Present?
Investigational therapies are finally achieving some success in treating Alzheimer’s disease, but a cure is not yet in sight. Medtech now has a golden opportunity in pre-symptomatic detection, according to digital health tech research initiative, EDoN.
You may also be interested in...
NeuroDiagnostics LLC said its investigational Alzheimer's disease test had been designated by US FDA as a Breakthrough Device. This is at least the third company to achieve that recognition for technology targeting Alzheimer's this year.
The $320k grant will support research that builds on IQuity’s autoimmune diagnostic expertise and new data analytics platform. The company believes the emerging therapies for Alzheimer's will be most effective if they are used to treat the disease early in its progression.
A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. Among the five added this week, Neuronix's NeuroAD Non Invasive Cortical Enhancer technology was approved in Australia for use in Alzheimer's patients, in combination with "tailored cognitive therapy."